A new study reported a mechanistic link between the receptor GPR84 and lung inflammation through ZBP1-PANoptosome activation in the context of influenza A virus infection, as described in the provided summary. Researchers identified how GPR84 exacerbates inflammatory cascades after IAV challenge, connecting a specific host-sensing axis to inflammatory cell death complex formation. The finding strengthens the rationale for targeting upstream inflammatory signaling rather than focusing only on viral clearance. If validated across models, the pathway could inform therapeutic development aimed at reducing severe respiratory inflammation during influenza. For drug developers, the work highlights a potential biomarker-and-target pairing around ZBP1-PANoptosome activity that may guide patient stratification in future preclinical and translational programs.